Author

K. Jurado

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

A. August· 2 shared E. Morrisey· 2 shared H. Aguilar-Carreno· 2 shared J. Yang· 2 shared M. Wang· 2 shared P. Hewins· 2 shared P. Mericko-Ishizuka· 2 shared S. Gao· 2 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

A. August

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Endothelial SARS-CoV-2 infection is not the underlying cause of COVID19-associated vascular pathology in mice

S. Gao, A. T. Tang, M. Wang, D. W. Buchholz, B. Imbiakha, J. Yang, X. Chen, P. Hewins, P. Mericko-Ishizuka, N. A. Leu, S. Sterling, A. August, K. Jurado, E. Morrisey, H. Aguilar-Carreno, M. L. Kahn

This study shows that endothelial SARS-CoV-2 infection does not significantly contribute to COVID-19-associated vascular pathology in mice.

bioRxiv · Jul 24, 2023 · PreprintPathology

SARS-CoV-2 infection of olfactory epithelial cells and neurons drives acute lung injury and lethal COVID-19 in mice

A. Tang, D. W. Buccholz, K. Szigety, B. Imbhiaka, S. Gao, M. Frankfurter, M. Wang, J. Yang, P. Hewins, P. Mericko-Ishizuka, N. Leu, S. Sterling, I. Monreal, J. Sahler, A. August, , M. Kahn

bioRxiv · Dec 4, 2021 · PreprintMicrobiology

Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2

M. Dittmar, J. S. Lee, K. Whig, E. Segrist, M. Li, K. Jurado, K. Samby, H. Ramage, D. Schultz, S. Cherry

The paper screens FDA-approved drugs against SARS-CoV-2 in different cell types, identifying three FDA-approved antivirals with potential for clinical use.

bioRxiv · Jun 19, 2020 · PreprintMicrobiology